Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Fortrea Holdings Inc. June 10, 202587.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Fortrea Holdings Inc. | Open-market sale | −9,700 | $18.01 | $174,697 |
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| Jun 10, 2026 | Fortrea Holdings Inc. | Option exercise | +38,817 | — | — |
| Nov 13, 2025 | BioCryst Pharmaceuticals Inc. | Open-market sale | −9,600 | $7.14 | $68,544 |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| May 14, 2025 | Fortrea Holdings Inc. | Option exercise | +7,282 | — | — |
| Jun 17, 2024 | BioCryst Pharmaceuticals Inc. | Open-market sale | −4,689 | $6.00 | $28,134 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| Jun 15, 2023 | BioCryst Pharmaceuticals Inc. | Open-market sale | −4,000 | $7.98 | $31,920 |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
Questions about Machelle Sanders
What boards is Machelle Sanders on?
Machelle Sanders sits on the boards of BioCryst Pharmaceuticals Inc. and Fortrea Holdings Inc.
How long has Machelle Sanders served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.